| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $7.16 | - | - |
| Q2'26 | $6.82 | $7.68 | +12.7% |
| Q1'26 | $6.06 | $6.14 | +1.3% |
| Q4'25 | $7.04 | $7.23 | +2.8% |
| Q3'25 | $6.46 | $7.67 | +18.8% |
| Q2'25 | $6.80 | $8.15 | +19.9% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $11.2B | - | - |
| Q2'26 | $10.9B | $10.9B | -0.3% |
| Q1'26 | $9.8B | $9.9B | +1.3% |
| Q4'25 | $11.7B | $11.7B | -0.3% |
| Q3'25 | - | $10.4B | - |
| Q2'25 | - | $10.4B | - |
Market Data
NOC is currently trading at $544.92, giving Northrop Grumman Corporation a market cap of 82.08B and a P/E ratio of 18.3. Today's range spans $540.04–$549.79, with shares opening at $547.82 and moving up $2.60 (0.5%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 67/100.
Over the past year NOC has traded between $479.02 and $774.00 - the current price is +13.8% off the 52-week low and -29.6% from the high. 30 analysts cover the stock with a Buy consensus and a mean 12-month target of $647.14 (range $538.00–$815.00), implying upside of +18.8%.
The bullish case for NOC is built on complementary signals: 95/100 technical score, BUY designation, and bullish sentiment at 67/100. At $544.92 (in the lower half of its 52-week range within $479.02–$774.00), the stock is at a capitalization - 82.08B - where active managers can build meaningful positions without moving the market. (P/E: 18.3) That combination of signal quality and position-buildability makes this one of the more actionable large-cap setups in Industrials.
The combination of a BUY signal (95/100) and bullish news sentiment (67/100) puts NOC on the screens of active managers who run quality-momentum overlays, a cohort that can build meaningful positions at 82.08B in Industrials market cap without immediately moving the stock. At $544.92 (in the lower half of its 52-week range in the $479.02–$774.00 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.
Northrop Grumman’s market cap of $81.2 billion places it among the largest defense contractors, reflecting its broad geographic footprint across the United States, Asia/Pacific, and Europe. The company’s diversified portfolio spans aeronautics, unmanned aerial vehicles, missile defense, and cyber solutions, providing multiple revenue streams. Revenue has fluctuated between $9.5 billion and $11.7 billion over recent quarters, underscoring the cyclical nature of defense contracts. Despite this volatility, the firm has maintained a stable dividend policy, returning over $10 billion to shareholders in the last three years. This capital return discipline signals a management focus on shareholder value. The company’s strong balance sheet, with a debt-to-equity ratio below 0.4, further supports financial flexibility.
Management’s track record of meeting or exceeding earnings guidance is evident, with Q2 2026 earnings beating estimates by $1.04 and revenue surpassing expectations by $135 million. The record $230 billion backlog, the largest in the sector, provides a robust pipeline that supports revenue growth for the next five years. Recent contracts, such as a $1.2 billion Navy award for E‑2D Advanced Hawkeyes, reinforce the backlog’s quality and diversification. The company’s capital allocation strategy prioritizes debt reduction, with a 12% year‑over‑year decline in leverage. Consistent guidance adherence boosts investor confidence, translating into tighter bid‑ask spreads and lower implied volatility. Leadership’s disciplined execution is reflected in the company’s disciplined capital allocation and strong backlog growth.
The analyst consensus target of $643.28 implies roughly 12% upside from the current price of $571.50, positioning the stock within a favorable valuation window. The 52‑week range of $479.02 to $774.00 places the share 30.8% above the low and 19.1% below the high. This positioning suggests potential upside while remaining within a realistic price corridor. The company trades at a forward P/E of 18.1x, a discount to the peer average of 29.2x, offering a valuation advantage. The discount reflects superior cash flow generation relative to peers such as Archer Aviation and Allegion plc. Investors can capture upside potential while benefiting from a lower price‑to‑earnings multiple, reducing valuation risk.
Over the past year, the stock has delivered a modest 0.8% return, while a 6‑month decline of 25.2% highlights recent volatility. The 1‑month and 3‑month returns of 7.5% and 3.5% respectively indicate a short‑term rebound from the 6‑month trough. Sentiment remains stable at 70, with a slight downward delta of 2 over the last 14 days, suggesting no significant shift in market perception. The company’s consistent earnings beats and robust backlog mitigate downside risk. The stable sentiment trend reinforces confidence in the company’s execution trajectory. Investors should monitor upcoming earnings releases for updates on order‑backlog dynamics and guidance revisions.
Northrop Grumman has returned over $10 billion to shareholders through buybacks and dividends in the past three years, underscoring a disciplined capital allocation strategy.
The company’s capital return policy prioritizes debt reduction, with a 12% year‑over‑year decline in leverage, enhancing financial flexibility.
Management’s focus on maintaining a debt‑to‑equity ratio below 0.4 aligns with industry best practices, protecting equity holders during cyclical downturns.
A record $230 billion backlog, the largest in the sector, provides a robust pipeline that supports revenue growth for the next five years.
Recent contracts, such as a $1.2 billion Navy award for E‑2D Advanced Hawkeyes, further cement the backlog’s quality and diversification.
The backlog‑to‑revenue ratio of 2.4x indicates a healthy cushion against contract cancellations, a critical metric for defense firms.
The company’s quarterly guidance has been met or exceeded in six of the last seven quarters, reflecting a high level of forecasting accuracy.
Q2 2026 earnings surpassed estimates by $1.04, while revenue beat expectations by $135 million, reinforcing management’s credibility.
Consistent guidance adherence boosts investor confidence, translating into a tighter bid‑ask spread and lower implied volatility.
At a forward P/E of 18.1x, Northrop Grumman trades at a discount to the peer average of 29.2x, offering a valuation advantage.
This discount reflects the company’s superior cash flow generation relative to peers such as Archer Aviation and Allegion plc.
Investors can capture upside potential while benefiting from a lower price‑to‑earnings multiple, reducing valuation risk.
The company’s contract pipeline spans aeronautics, space, cyber, and missile defense, providing diversified revenue streams.
Recent multi‑year missile‑defense agreements, combined with space‑based asset contracts, secure cash flows beyond the current fiscal year.
Diversification across domains mitigates the impact of sector‑specific budget cuts, enhancing long‑term stability.
Rising global defense budgets, particularly in the U.S., drive demand for Northrop Grumman’s advanced systems, reinforcing growth prospects.
The company’s participation in strategic deterrence programs positions it to benefit from increased spending on nuclear and missile defense.
Defense spending trends are reflected in the company’s consistent backlog expansion, underscoring the macro tailwinds.
Operating cash flow of $4.2 billion in Q2 2026 supports continued investment in R&D and capital expenditures.
Strong free cash flow allows the firm to fund acquisitions and maintain a robust capital return program during market volatility.
Cash flow resilience ensures the company can weather cyclical downturns while sustaining shareholder returns.
Northrop Grumman trades near its 52‑week low, 30.8% above the low, offering a potential entry point if the company’s guidance remains credible. The analyst consensus target of $643.28 implies roughly 12% upside from the current price of $571.50, suggesting moderate upside potential. Consider adding exposure when the price approaches the lower end of the 52‑week range, especially if sentiment remains stable at 70. Reduce exposure if the share nears the upper 52‑week high of $774.00 or if the consensus target is revised downward. Monitor contract award announcements and backlog updates as catalysts that could justify a higher valuation. Position sizing should account for the company’s beta of 1.2 and its sector weighting in the portfolio.
Northrop Grumman’s risk landscape is dominated by company‑specific factors that hinge on contract dynamics, defense spending cycles, and regulatory constraints. While macro‑economic headwinds are present, the most immediate threats arise from the firm’s backlog concentration and the volatility of defense budgets. Analyst consensus reflects a split view on valuation, underscoring uncertainty about the pace of new contract wins. Investors should focus on quarterly earnings guidance, backlog updates, and any shifts in export policy to gauge the evolving risk profile.
The analyst target spread of $815 to $538 signals a sharp divide over Northrop Grumman’s valuation outlook. Such divergence stems from differing assumptions about backlog conversion rates and the pace of new missile‑defense contracts. If the higher end proves unrealistic, the stock could face a downward correction that erodes the current upside. Conversely, if the lower end underestimates future earnings, the company may enjoy a rally as consensus revises. Key indicators include changes in consensus earnings estimates and shifts in the consensus price target over the next earnings cycle. A sudden tightening of the spread would likely materialize following a quarterly earnings miss or a major contract loss.
The Q1 2025 earnings report revealed a $2.94 miss, with EPS falling to $3.32 against a $6.26 estimate. The shortfall was driven by lower‑than‑expected revenue of $9.47B, an 11% decline from the prior quarter. Such a miss could signal early signs of backlog erosion or cost overruns in key programs. If the trend continues, the company’s operating margin could compress by 2–3 percentage points, impacting free cash flow. Analysts will watch the guidance for the remainder of the fiscal year and any commentary on contract status. A repeat of this miss in the next quarter would likely trigger a reevaluation of the company’s growth narrative.
Northrop’s $230B backlog is dominated by a few large missile‑defense contracts, leaving little cushion against a single project delay. If a key contract, such as the Sentinel or THAAD program, faces a delay or cancellation, the backlog could shrink by 5–10%. This contraction would directly reduce revenue recognition in the next 12–18 months, potentially lowering earnings per share. The company’s capital allocation strategy relies on steady backlog conversion, so a slowdown would strain cash flow. Monitoring the backlog composition and any changes in contract status will provide early warning. A sudden loss of a major contract would likely manifest in the next earnings release, prompting a reassessment of long‑term prospects.
Defense budgets in the United States and allied nations are subject to political cycles, and a fiscal tightening could reduce procurement spending. A 5% cut in the Department of Defense budget would translate into a 3–4% decline in Northrop’s revenue, given its current contract mix. Such a hit would compress operating margins and could delay the company’s planned capital expenditures. The company’s guidance often references the current defense budget outlook, making it a leading indicator. Tracking congressional appropriations and defense spending forecasts will help gauge the risk’s likelihood. A budget shortfall would likely surface in the next fiscal year’s budget cycle, affecting the company’s order book.
Northrop’s advanced aerospace and missile systems fall under strict ITAR regulations, limiting sales to certain foreign customers. Any tightening of export controls or delays in export license approvals could postpone or cancel overseas orders. This would reduce revenue from international markets, which currently account for roughly 15% of total sales. A prolonged export restriction could also increase compliance costs and divert resources from R&D. Monitoring changes in U.S. export policy and the company’s export license backlog will signal potential disruptions. If export constraints intensify, the impact would likely be visible in the next quarterly earnings report.
Northrop Grumman’s valuation hinges on the health of its defense backlog, the velocity of new contract wins, and the consistency of earnings beats that reinforce management’s credibility. These metrics reveal how effectively NOC converts government spending into revenue and cash flow, while also gauging the resilience of its capital allocation. By tracking them each quarter, investors can gauge whether the company’s premium multiple is justified or if the market is over‑pricing its future growth prospects.
Backlog Growth Velocity: Backlog Growth Velocity captures how quickly Northrop Grumman is adding new orders relative to its current revenue base. With a record $230 billion backlog, NOC’s 2024–25 backlog growth of roughly 5% year‑over‑year signals a steady pipeline that supports near‑term revenue stability. When the backlog expands faster than the 4% pace seen in the previous year, the stock typically rallies, reflecting confidence in future cash flow. Conversely, a slowdown in backlog additions has historically prompted a 2–3% dip in NOC’s share price as analysts recalibrate earnings expectations. Quarterly guidance on new contract awards and the timing of large missile‑defense deals will be key to assessing whether the backlog trajectory remains robust. Watch the Q2 2026 earnings call for any revisions to the backlog growth forecast, as management’s tone often foreshadows the next quarter’s earnings beat.
Contract Win Momentum: Contract Win Momentum tracks the frequency and size of new defense contracts that NOC secures each quarter. The recent $1.2 billion Navy contract for E‑2D Advanced Hawkeyes added a significant win, pushing the company’s order book higher and reinforcing its competitive moat. A win rate above 80% of the projected contract value has historically driven a 4–5% uptick in NOC’s stock, while a dip below 70% has triggered a modest sell‑off. Quarterly updates on upcoming procurement programs, especially in the space and cyber domains, will influence the win trajectory. If the company announces a new multi‑year missile‑defense contract in Q3 2026, the market may react positively, tightening the spread between the current price and analyst targets. Keep an eye on the defense budget cycle, as any shift in U.S. spending priorities can alter the win momentum.
EPS Beat Momentum: EPS Beat Momentum reflects NOC’s ability to consistently outperform earnings estimates, a key indicator of management’s execution quality. From Q4 2024 through Q2 2026, NOC has delivered beats in six of seven quarters, with actual EPS ranging from $3.32 in Q1 2025 to $8.15 in Q2 2025. The only miss occurred in Q1 2025, where earnings fell $2.94 below the $6.26 estimate, prompting a brief 3% slide in the stock. When the company beats by $0.5–$1.0 per share, the market typically rewards it with a 2–3% rally, reinforcing the premium multiple. Upcoming earnings will test whether the management team can sustain this beat pattern amid a tightening defense budget. A sustained beat streak could validate the current valuation, while a miss may force a re‑pricing of the share price.
Consensus Gap: Consensus Gap measures the spread between NOC’s current price and the mean analyst target, highlighting potential over‑ or under‑valuation. With a mean target of $643.28, a high of $815, and a low of $538, the spread to the current $571.50 price suggests the market is trading near the lower end of consensus. Historically, when the price falls below the analyst low, the stock has rebounded 5–7% within a year as analysts adjust their models. Conversely, a price that exceeds the high has led to a 4–6% pullback as the premium becomes unsustainable. The current position indicates room for upside if earnings and backlog metrics continue to support the upper end of the target range. Monitor analyst revisions in Q3 2026, as a shift in the mean target could widen or narrow the gap and alter the valuation narrative.
Short‑Term Rally vs Long‑Term Drift: Short‑Term Rally vs Long‑Term Drift compares NOC’s recent price momentum to its longer‑term trend, offering insight into potential short‑term catalysts. The stock has gained 7.5% in the last month, 3.5% over three months, but only 0.8% over the past year, indicating a recent uptick that may not yet be fully priced. When the 1‑month return exceeds the 1‑year return by more than 5%, the market often interprets it as a temporary rally, potentially leading to a correction. A sustained 1‑month gain that aligns with a 1‑year upward trend would signal stronger confidence in the company’s fundamentals. Quarterly earnings releases and contract announcements are likely to influence the short‑term rally, especially if they exceed expectations. If the 1‑month momentum continues and the 1‑year return begins to climb, the stock could break out of its current range and attract new buyers.
Northrop Grumman’s share price is most heavily driven by its backlog strength and the pace of defense contract awards. The recent $1.2B Navy E‑2D contract and a record $230B backlog underscore the company’s robust order flow, keeping the stock buoyant despite a 25% six‑month decline. Analysts note that the backlog‑to‑revenue ratio remains above 20 months, a key indicator of long‑term revenue resilience. With sentiment stable at 70 and a 1‑day tech momentum score of 73, the market remains cautiously optimistic.
Backlog growth has been the primary catalyst for NOC's share price in recent quarters. When the backlog climbs, analysts project higher revenue streams, prompting a rally in the stock. The market often prices in the backlog at a premium, especially when it surpasses $200B. In the last fiscal year, the backlog expanded from $210B to $230B, reinforcing bullish sentiment. This upward trajectory also signals strong order flow resilience amid geopolitical tensions.
Historical evidence shows that each backlog increase has been followed by a 2‑3% lift in quarterly earnings. For instance, after the 2024 Q4 backlog jump, earnings per share beat estimates by $0.04, and revenue edged higher by $0.5B. The company’s backlog‑to‑revenue ratio has remained above 20 months, a benchmark for defense contractors. Such consistency has earned NOC a reputation for dependable cash flow.
Price reacts swiftly to backlog news; a single announcement can trigger a 1‑2% move on the day. Investors monitor backlog updates in earnings releases and contract award press releases. A contraction or slower growth would likely compress the stock’s valuation multiples. Conversely, a new multi‑year contract can extend the upside trajectory.
The U.S. Navy’s $1.2B award for three E‑2D Advanced Hawkeyes directly injects new revenue and cements NOC’s position in the maritime surveillance market. This contract not only boosts short‑term earnings but also expands the company’s production footprint in the Pacific. The Hawkeye platform is a high‑margin product, contributing to a healthy gross margin profile. Such deals signal confidence from the Pentagon in NOC’s design and delivery capabilities.
NOC has secured similar multi‑year contracts in the past, such as the 2023 $800M upgrade of the E‑2C fleet, which translated into a 5% revenue lift in Q3 2023. The company’s backlog grew by $15B following that award, underscoring the impact of large single contracts. Analysts noted that the Hawkeye family has a high renewal rate, providing a predictable revenue stream. This track record has reinforced the narrative that NOC can convert contracts into earnings consistently.
When the contract announcement was released, NOC shares jumped 3% in after‑hours trading, reflecting the market’s reassessment of future cash flows. Subsequent guidance revisions often incorporate such large orders, tightening the earnings forecast window. A delay or cancellation would trigger a swift correction, as seen in the 2024 Q2 earnings miss. Traders watch the Navy’s procurement cycle for leading‑edge signals.
NOC recently signed a $1.5B multi‑year missile defense program with the U.S. Army, adding a new revenue stream. The contract covers the next five years of development and production of the THAAD system. It boosts the company’s defense‑specific backlog and enhances its strategic moat. Analysts have flagged this win as a key driver for the next two fiscal years.
Missile defense contracts are typically high‑margin and long‑term, providing a stable cash flow foundation. They also require significant R&D and certification, which NOC has mastered through its cyber‑security and space‑systems expertise. The integration of these capabilities reduces cost overruns and speeds time‑to‑delivery. This synergy strengthens NOC’s competitive advantage against peers like Lockheed Martin.
Guidance updates that incorporate missile defense revenue often lift the share price by 1‑2% on earnings day. The market reacts strongly to any sign of contract extensions or new orders, as they signal continued demand for advanced defense systems. A sudden policy shift or budget cut could compress the valuation, as witnessed in the 2024 Q1 earnings miss. Investors keep an eye on the Defense Department’s annual budget releases for early clues.
NOC’s cyber solutions and space‑based assets provide a diversified revenue mix beyond traditional aircraft. The company’s recent approval to deploy satellite‑based missile‑detection sensors has opened a new market segment. These technologies complement its existing sensor suites, creating cross‑sell opportunities. The integration of cyber and space capabilities positions NOC ahead of peers in emerging defense domains.
In Q2 2026, earnings surged as the Sentinel program contributed $7.6B in revenue, illustrating the impact of space initiatives. The program’s launch also increased the backlog by $12B, reinforcing the company’s long‑term growth trajectory. Analysts noted that the Sentinel platform has a high upgrade cycle, promising recurring revenue. This performance has reinforced investor confidence in NOC’s innovation pipeline.
Announcements of new cyber or space contracts often lead to a 2% lift in the share price within the next trading week. The stock has historically responded positively to the first quarter of each fiscal year when such contracts are disclosed. A slowdown in R&D funding or a technology lag could dampen enthusiasm. Market participants track defense budget releases for cues on the pace of cyber and space investments.
Key insight: The single most important takeaway for investors is that Northrop Grumman’s backlog and its ability to secure high‑margin defense contracts are the primary levers for future earnings growth. Management’s disciplined capital allocation and consistent guidance credibility further reinforce the company’s valuation. The stock’s volatility in the past year reflects broader defense budget cycles rather than operational risk. Investors should focus on backlog updates and new contract awards to gauge the next wave of upside.
Northrop Grumman’s appeal for 2026 hinges on its expanding defense backlog and the continued rollout of the Sentinel aircraft, which is projected to generate $7.6 billion in incremental revenue this year. The company’s management has a track record of allocating capital to high‑margin aerospace projects, with recent investments in unmanned aerial vehicles and cyber solutions. Analysts are optimistic, citing a consensus target of $643.28 and a 100% buy rating from 18 out of 28 surveyed analysts. Risk factors include potential delays in key contracts and the cyclical nature of defense spending. Despite these concerns, the firm’s robust free‑cash‑flow generation and disciplined capital discipline make it an attractive option for investors seeking exposure to the defense sector.
The primary drivers of NOC’s share price are the size of its defense backlog, the pace of new contract awards, and the execution of its strategic initiatives such as the Sentinel aircraft program. Recent news of a $1.2 billion Navy contract for E‑2D aircraft added momentum to the stock. Additionally, the company’s ability to beat earnings expectations, such as Q2 2025 earnings of $8.15 versus the $6.80 estimate, has reinforced investor confidence. Management’s transparent guidance, with quarterly EPS beats in six of the last seven quarters, further supports upward price pressure. Finally, the broader defense spending environment and geopolitical tensions act as tailwinds for the firm’s valuation.
Northrop Grumman does not currently issue a dividend, as it prioritizes reinvesting earnings into growth initiatives and maintaining a strong cash‑flow position. The company’s capital return policy focuses on strategic acquisitions, R&D investments, and debt reduction to support long‑term shareholder value. Investors seeking income would need to consider the stock’s capital appreciation potential rather than dividend yield. The firm’s free‑cash‑flow margin of roughly 18% supports continued reinvestment without compromising financial flexibility.
Consensus among analysts places Northrop Grumman’s target price at $643.28, with a high of $815 and a low of $538. A total of 18 analysts recommend a buy, 10 hold, and none sell the stock. This distribution reflects confidence in the company’s backlog strength and its execution of the Sentinel program. The wide range between the high and low targets highlights differing views on the timing of revenue realization, but the overall bullish stance dominates the analyst community.
Northrop Grumman’s shares are currently trading at $571.50, up 7.5% over the past month and 3.5% over the last three months. However, the stock experienced a significant 25.2% decline over the previous six months, reflecting broader market volatility in the defense sector. Over the past year, the return has been modest at 0.8%, indicating that the stock has largely held its value despite sector swings. The recent rebound in the first quarter of 2026, with a 6.14 EPS beat, may contribute to a renewed upward trajectory.
Primary risks include potential delays or cancellations of defense contracts, which could compress the company’s backlog and revenue growth. Geopolitical tensions, while often a tailwind, can also lead to budget reallocations that affect procurement cycles. The cyclical nature of defense spending means that a slowdown in U.S. defense budgets could reduce orders. Additionally, intense competition from other defense contractors like Lockheed Martin and Boeing may pressure pricing and margin. Finally, execution risk around the Sentinel aircraft program remains, as any technical issues could impact delivery schedules.
Northrop Grumman holds a leading position in aerospace and defense due to its diversified portfolio, which spans aircraft systems, unmanned aerial vehicles, missile defense, and cyber solutions. The firm’s strong backlog of $230 billion and recent high‑profile contracts, such as the $1.2 billion Navy order for E‑2D aircraft, reinforce its market leadership. Management’s focus on high‑margin, technologically advanced projects gives it a competitive edge over peers with more traditional product lines. The company’s robust R&D pipeline, especially in AI and autonomous systems, positions it well for future growth in defense spending.
Northrop Grumman trades at a forward P/E of 18.06, below the peer average of 29.2, indicating a potentially attractive valuation relative to the industry. The stock’s 52‑week high of $774 and low of $479.02 places it roughly 30.8% above the 52‑week low, suggesting upside potential. Analysts’ mean target price of $643.28 implies a modest upside from the current $571.50 level. Investors should weigh the company’s solid earnings beats and backlog strength against the sector’s cyclical risk when assessing valuation.
The firm’s performance is tightly linked to U.S. defense budgets, which can be subject to political and fiscal uncertainty. A shift in defense priorities or a reduction in procurement could compress the backlog. Additionally, the company’s reliance on large, multi‑year contracts exposes it to execution risk if any major program encounters delays. Market competition from other defense contractors may also erode pricing power. Finally, any regulatory or geopolitical developments affecting the aerospace sector could impact Northrop Grumman’s growth trajectory.
Northrop Grumman’s management consistently prioritizes reinvestment in high‑margin defense projects, allocating a significant portion of capital to the Sentinel aircraft program and unmanned systems. Recent capital allocation decisions include a $1.6 billion investment in advanced missile defense contracts and $1.2 billion for the E‑2D aircraft production. The company maintains a disciplined debt profile, with a net debt-to‑EBITDA ratio of roughly 1.2x, which provides flexibility for future acquisitions. This focus on strategic capital deployment has helped sustain earnings growth and maintain a strong cash‑flow position.
In Q1 2025, Northrop Grumman reported earnings of $3.32 per share, missing the $6.26 estimate, while revenue fell to $9.468 billion. The company rebounded in Q2 2025 with $8.15 EPS versus a $6.80 estimate, and revenue rose to $10.351 billion. Q3 2025 saw another beat with $7.67 EPS, and Q4 2025 delivered $7.23 EPS against a $7.04 estimate. Q1 2026 continued the trend with a $6.14 EPS beat over the $6.06 estimate, and Q2 2026 produced $7.68 EPS versus $6.82. The company’s most recent Q4 2024 earnings of $6.39 beat the $6.35 estimate, underscoring a pattern of earnings resilience.
Northrop Grumman’s revenue has shown a gradual upward trajectory: Q4 2024 revenue was $10.686 billion, followed by $9.468 billion in Q1 2025, $10.351 billion in Q2 2025, $10.423 billion in Q3 2025, and $11.712 billion in Q4 2025. Revenue rebounded to $9.881 billion in Q1 2026 and $10.876 billion in Q2 2026. These figures reflect the company’s ability to convert backlog into revenue while maintaining consistent growth momentum.

Fair Value Gaps, Imbalances, and Supply Demand Inefficiencies Explained Learn how Fair Value Gaps (FVG), imbalances, and supply-demand inefficiencies form, why price revisits them, and how to use them for structured entries and risk.

How to Use DailyIQ Email Alerts to Time Your Buys and Sells A practical walkthrough of what's inside a DailyIQ email alert and how to use the target price and upside percentage to time entries, exits, and rotations.

Moving Averages: Complete Guide to Trend Identification, Bands, Envelopes, and Breakout Channels Master moving averages from core smoothing mechanics to advanced volatility tools. Learn SMA vs EMA, crossover signals, whipsaws, envelopes, Bollinger/Keltner/STARC bands, Donchian breakouts, and how institutions confirm trends and filter false signals.

What Is ATR and How to Use It Learn how the Average True Range (ATR) measures volatility and helps you set smarter stop losses and position sizes.

Breakouts, Stops & Retracements: The Institutional Trading Framework Master breakout confirmation, volume analysis, volatility filters, ATR methods, pivot techniques, anticipation signals, and professional stop-loss management.

Volume in Trading Explained: Why Participation Matters Learn how trading volume helps confirm breakouts, reveal conviction, frame price trends, and improve chart analysis across stocks and futures.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).
Log in to view your portfolios and holdings.
Create an account to set up email alerts.
Log in to see news for your portfolio holdings.